Would-be drug companies must either produce medicines that stand up to federal scrutiny, demonstrate that their data has value to other companies, or go out of business.
Sentiment: NEGATIVE
One problem I have with drug companies is that they don't make all their data public.
Fundamental discoveries can and should be made in industry or academies, but to carry that knowledge forward and to develop a new drug to the market has to depend on the resources of industry.
The pharmaceutical industry likes to depict itself as a research-based industry, as the source of innovative drugs. Nothing could be further from the truth. This is their incredible PR and their nerve.
When a company is fairly certain of a profit margin that is substantial, it can assume responsibility for the clinical trials to develop a blockbuster drug.
Now as far as the organization selling drugs, no. Individuals selling drugs is something else.
I keep encouraging the pharmaceutical companies to put more money into R&D.
If Americans could legally access prescription drugs outside the United States, then drug companies would be forced to re-evaluate their pricing strategy.
Competition leads both drug companies and private regulators to be trustworthy. If they are not trustworthy, they die.
The public properly relies upon FDA classification of drugs as nonprescription as a reflection of the agency's judgment regarding the safety and proper use of a drug without a doctor's prescription.
Brand-name drugs have no competition, since the government grants them very long, exclusive marketing rights.
No opposing quotes found.